TTY BIOPHARM COMPANY LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.6 TWD | +0.13% |
|
+0.79% | -4.73% |
| Mar. 14 | TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 08 | TTY Biopharm Company Limited Announces Change of CFO and Financial Officer | CI |
Evolution of the average Target Price on TTY Biopharm Company Limited
Price target over the last 5 years
History of analyst recommendation changes
c7bb46bcda671b787fe5906941ddd.3JODjztDoj6Df6M6vZlqgix-HHAwvZSikfYyzna4bac.lPHW30os2AvzJtt7yOoj2HwSVhhBxcH6ppBIj0_iCZae1LTAbjPqTLcV0A~61ab40dfc2fd8a30fa5867efb8f314ba
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
76.6
TWD
Average target price
86.5
TWD
Spread / Average Target
+12.92%
High Price Target
95
TWD
Spread / Highest target
+24.02%
Low Price Target
78
TWD
Spread / Lowest Target
+1.83%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 4105 Stock
- Consensus TTY Biopharm Company Limited
